Bioservo: Edging closer to the inflection point - Redeye

Redeye adjusts the short-term estimates downward due to a slightly more challenging business environment. The changes in estimates negatively affect our fair value range; however, we are still optimistic about the long-term prospects of both Ironhand and Carbonhand. We lower our Base case to SEK 16 (18) per share.

Länk till analysen i sin helhet: https://www.redeye.se/research/840477/bioservo-edging-closer-to-the-inflection-point?utm_source=finwire&utm_medium=RSS